# Sutter Health

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/sutter-health/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 81.1 |
| Citations | 100,073 |
| City | Sacramento |
| Country | US |
| Description | Sutter Health is a research organisation in Sacramento, US. OpenAlex records 2,286 works and 100,073 citations for it. 697 researchers list it as their most recent affiliation. |
| Homepage | http://www.sutterhealth.org/ |
| OpenAlex ID | https://openalex.org/I114073160 |
| Researchers | 697 |
| ROR ID | https://ror.org/0060avh92 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q7650154 |
| Works | 2,286 |

## University papers

Showing 12 of 20.

- [Consensus statement on the pathology of IgG4-related disease](https://scholariq.org/papers/consensus-statement-on-the-pathology-of-igg4-related-disease/)
- [The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women](https://scholariq.org/papers/the-effect-of-raloxifene-on-risk-of-breast-cancer-in-postmenopausal-women/)
- [Calcium plus Vitamin D Supplementation and the Risk of Fractures](https://scholariq.org/papers/calcium-plus-vitamin-d-supplementation-and-the-risk-of-fractures/)
- [Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA](https://scholariq.org/papers/sensitive-and-specific-multi-cancer-detection-and-localization-using-methylation/)
- [The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women](https://scholariq.org/papers/the-use-of-clinical-risk-factors-enhances-the-performance-of-bmd-in-the/)
- [Sarcopenia With Limited Mobility: An International Consensus](https://scholariq.org/papers/sarcopenia-with-limited-mobility-an-international-consensus/)
- [Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis](https://scholariq.org/papers/short-physical-performance-battery-and-all-cause-mortality-systematic-review-and/)
- [Inherited Mutations in Women With Ovarian Carcinoma](https://scholariq.org/papers/inherited-mutations-in-women-with-ovarian-carcinoma/)
- [Recommendations for the nomenclature of IgG4‐related disease and its individual organ system manifestations](https://scholariq.org/papers/recommendations-for-the-nomenclature-of-igg4-related-disease-and-its-individual/)
- [Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial](https://scholariq.org/papers/bevacizumab-and-paclitaxel-carboplatin-chemotherapy-and-secondary-cytoreduction/)
- [Sarcopenia and Cardiovascular Diseases](https://scholariq.org/papers/sarcopenia-and-cardiovascular-diseases/)
- [Prevalence of Osteoporosis and Fracture in China](https://scholariq.org/papers/prevalence-of-osteoporosis-and-fracture-in-china/)

## University top topics

Showing 8 of 25.

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Global Cancer Incidence and Screening](https://scholariq.org/topics/global-cancer-incidence-and-screening/)
- [Primary Care and Health Outcomes](https://scholariq.org/topics/primary-care-and-health-outcomes/)
- [Electronic Health Records Systems](https://scholariq.org/topics/electronic-health-records-systems/)
- [Healthcare Policy and Management](https://scholariq.org/topics/healthcare-policy-and-management/)
- [Cervical Cancer and HPV Research](https://scholariq.org/topics/cervical-cancer-and-hpv-research/)
- [Palliative Care and End-of-Life Issues](https://scholariq.org/topics/palliative-care-and-end-of-life-issues/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.